Felix Preisser

18PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersInstruments and techniquesMedical biotechnology diagnostics (incl. biosensors)Oncology and carcinogenesis not elsewhere classifiedRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Feb 13, 2025
Patient-Reported Outcome Measures and Decision Regret After Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following Radiotherapy or Focal Therapy.

Fabian Falkenbach, Johanna Hagemann, Francesca Ambrosini

|Jan 11, 2025
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI® Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final Histology.

Giovanni Mazzucato, Fabian Falkenbach, Marie-Lena Schmalhofer

|Jun 19, 2024
Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center.

Benedikt Hoeh, Mike Wenzel, Clara Humke

|Oct 28, 2023
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer.

Fabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt

|Jun 28, 2023
Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy.

Felix Preisser, Reha-Baris Incesu, Pawel Rajwa

|Mar 28, 2022
Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer.

Felix Preisser, Alexander Heinze, Raisa S Abrams-Pompe

Pageof 3

Frequent Collaborators

10 joint publications

Derya Tilki

4 joint publications

Raisa S Pompe

3 joint publications

Tobias Maurer

3 joint publications

Fabian Falkenbach